超越糖尿病的甲福明:对抗衰老和癌症的一种精密的老年治疗和免疫代谢辅助剂
Abdul Rehman1, Shakta Mani Satyam2, Mohamed El-Tanani3
1Department of Pathology, RAK College of Medical Sciences, RAK Medical and Health Sciences University, Ras Al Khaimah 11172, United Arab Emirates.
Cancers
|August 14, 2025
概括
甲福明是一种抗糖尿病药物,显示出作为日经治疗和癌症治疗辅助剂的前景. 它影响衰老和癌症途径,临床数据表明癌症风险降低和健康状况改善.
科学领域:
- 老年学是一门学科.
- 在瘤学瘤学.
- 免疫代谢过程中的免疫代谢.
- 药理学 药理学是指药理学的学科.
背景情况:
- 甲胺是一种广泛使用的抗糖尿病药物.
- 新兴研究强调了其作为老年治疗剂和癌症免疫治疗中的辅助剂的潜力.
- 它的机制涉及与代谢,免疫,表观遗传和微生物组途径的复杂相互作用.
研究的目的:
- 审查甲胺在衰老和癌症中的作用的分子机制.
- 批判性地分析临床试验数据关于甲福明在衰老和瘤学中的有效性.
- 为了比较甲福明与其他老年治疗药物和老年治疗药物.
主要方法:
- 文献综述和机械学研究的综合.
- 从关键临床试验 (例如,UKPDS,CAMERA,TAME,MA.32,METTEN) 的数据分析.
- 与新兴的抗衰老和抗癌疗法进行比较评估.
主要成果:
- 甲胺调节与衰老和癌症生物学相关的关键途径.
- 临床证据表明,甲福明可以降低癌症发病率,改善免疫治疗反应,延迟疾病,并逆转衰老标志物.
- 试验表明甲福明对代谢健康,心血管风险和与年龄有关的疾病的影响.
结论:
- 甲胺表现出多种药物,对衰老和癌症有重大影响.
- 它为准确医学策略提供了潜力,针对共同的衰老和癌症根源.
- 未来的研究应该专注于优化剂量,个性化和组合疗法,以扩大适应症.
相关概念视频
Oral Hypoglycemic Agents: Biguanides and Glitazones
296
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
296
Combination Therapies and Personalized Medicine
5.1K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K
Psychoneuroimmunology: Diabetes and Cancer
62
Chronic stress has been linked to both the onset and progression of serious health conditions, including Type 2 diabetes and cancer. Type 2 diabetes, a widespread chronic illness, is closely associated with obesity and insulin resistance, both of which often worsen under stress. Studies indicate that men experiencing high levels of chronic stress face a 45% higher risk of developing diabetes compared to those with minimal stress. Stress triggers physiological responses that elevate blood...
62
Tumor Immunotherapy
660
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
660
mTOR Signaling and Cancer Progression
3.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.9K
Insulin: Dosing Regimen and Adverse Effects
259
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
259


